Cannara Biotech Inc (LOVE) — Capital Reinvestment Ratio
Cannara Biotech Inc (LOVE) has a Capital Reinvestment Ratio of 0.58x as of November 2025, meaning it reinvests 1% of its operating cash flow (CA$7.96 Million) in capital expenditures (CA$4.62 Million). Check LOVE intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cannara Biotech Inc Capital Reinvestment Ratio (2023–2025)
This chart tracks Cannara Biotech Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see LOVE cash flow metrics.
Annual Capital Reinvestment Ratio for Cannara Biotech Inc (2023–2025)
Year-by-year Capital Reinvestment Ratio for Cannara Biotech Inc from 2023 to 2025. See Cannara Biotech Inc (LOVE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CA$20.01 Million | CA$6.36 Million | ▼ -54.6% |
| 2024 | 0.70x | CA$10.68 Million | CA$7.47 Million | ▼ -58.2% |
| 2023 | 1.67x | CA$5.91 Million | CA$9.88 Million | — |